Pertussis in Colombia
In August 2012, CDC-Latin American Pertussis Project conducted an initial assessment of the pertussis surveillance system and laboratory capacity in Colombia. Colombia’s Ministry of Health uses a standardized data collection form and case definitions for pertussis (known as tos ferina). The national reference laboratory, the Microbiology Group of the Instituto Nacional de Salud (INS) (in Spanish), and two regional laboratories have diagnostic capacity in culture, real-time polymerase chain reaction (PCR), and serology. Colombia’s national reference laboratory uses serology to support outbreak diagnostics. In 2014, they implemented real-time PCR as a primary diagnostic for pertussis and discontinued use of direct fluorescent antibody test (DFA).
The case definition for a suspected case of pertussis in Colombia includes three age groups:
- Under 3 months: All acute respiratory infections with at least one of the following symptoms:
- Coughing fits (paroxysmal cough)
- Posttussive vomiting
- 3 months through 12 years: Intense paroxysmal cough of any duration accompanied by stridor OR, in absence of a more likely diagnosis, all acute respiratory infections with cough for more than 7 days with one or more of the following symptoms:
- Paroxysmal cough
- Posttussive vomiting
- Over 12 years: All respiratory infections with cough for more than 14 days regardless of the presence of paroxysmal cough, expectoration, or posttussive vomiting
Pertussis cases are confirmed if they meet the case definition and have positive laboratory confirmation (by culture or PCR), are epidemiology linked to a laboratory-confirmed case, or are confirmed by clinical criteria (if no sample was taken or an inadequate sample was collected) as indicated in Colombia’s surveillance guidelines for pertussis [42 pages] (in Spanish).
- DTP – Diphtheria and tetanus toxoids and whole cell pertussis vaccine
- Tdap – Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
- HB – Hepatitis B vaccine
- Hib – Haemophilus influenzae serotype b vaccine
Colombia’s routine pertussis immunization program includes a pentavalent vaccine, which contains DTP (whole cell pertussis component), HB, and Hib, administered at 2, 4, and 6 months, with a booster of DTP given at 18 months and 5 years. In 2013 Colombia’s Ministry of Health recommended a dose of Tdap during every pregnancy (to be administered starting at 26 weeks gestation).
View Colombia’s complete vaccination schedule [2 pages] (in Spanish).
- Colombia’s guidelines for surveillance of pertussis [16 pages] (in Spanish)
- Colombia’s case reporting form for pertussis [3 pages] (in Spanish)
- Colombia’s laboratory guidelines for pertussis (in Spanish)
- Colombia’s surveillance bulletins (in Spanish)
- Page last reviewed: August 7, 2017
- Page last updated: August 7, 2017
- Content source: